In a letter, the director of the state Office of Medical Marijuana called the sale proposal “disturbing,” and on Monday Franklin Labs “took the offer off the table,” the Philadelphia Inquirer reported.

The company instead said that it had proposed to sell 100% of the stock of the company, and had included the permit as an asset, but that the company itself was never for sale, the Inquirer reported.

The proposal, however, was rescinded once the state MMJ director slapped the company on the wrist and demanded copies of all the sales prospectuses Franklin Labs has, along with other materials such as all possible buyers.

None of the Pennsylvania MMJ permits awarded to companies may be sold or transferred without state approval.